Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity

Curr Opin Infect Dis. 2012 Feb;25(1):26-35. doi: 10.1097/QCO.0b013e32834ef56c.


Purpose of review: The 2009 pandemic HIN1 influenza strain (H1N12009) produced more severe disease and increased risk for mortality. As an at-risk population for more severe influenza illness, particular concern regarding HIV patients triggered a focused effort to evaluate disease burden and vaccine efficacy in these populations.

Recent findings: As with other immune-compromised individuals, most HIV-infected individuals recovered without major consequence. Although HIV infection was assumed to be a risk factor for more severe disease and death, the published literature does not indicate this to be so. Neuraminadase inhibitors were well tolerated by this population and there was no evidence of clinically significant pharmacokinetic interactions with antiretroviral therapy. Immunogenicity was increased with H1N12009 vaccine compared to the historical results of nonpandemic vaccines and optimized by the use of adjuvants. Booster dosing was also of benefit. H1N12009 vaccine was generally well tolerated without evidence of detrimental effect on HIV status.

Summary: The worse case scenario was not realized for H1N12009 in the general population or in those with HIV. Immunization with adjuvant represents a key measure to protect this population from H1N12009 and other future novel influenza strains.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections* / drug therapy
  • AIDS-Related Opportunistic Infections* / epidemiology
  • AIDS-Related Opportunistic Infections* / virology
  • Antiretroviral Therapy, Highly Active
  • Disease Susceptibility / immunology
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / immunology
  • HIV Infections* / virology
  • Humans
  • Influenza A Virus, H1N1 Subtype* / immunology
  • Influenza Vaccines* / immunology
  • Influenza Vaccines* / therapeutic use
  • Influenza, Human* / drug therapy
  • Influenza, Human* / epidemiology
  • Influenza, Human* / immunology
  • Influenza, Human* / virology
  • Pandemics*


  • Influenza Vaccines